<?xml version="1.0" encoding="UTF-8"?>
<vetsafetymessage xsi:schemaLocation="http://eudravigilance.ema.europa.eu/schema/eudraveterinary http://eudravigilance.ema.europa.eu/schema/eudraveterinary.xsd" lang="EN" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://eudravigilance.ema.europa.eu/schema/eudraveterinary">
	<ichicsrmessageheader>
		<messagetype>VETADR</messagetype>
		<messageformatversion>2.2</messageformatversion>
		<messageformatrelease>1.0</messageformatrelease>
		<messagenumb>E2001_P_VETADR_H_H</messagenumb>
		<messagesenderidentifier>EVVETPRODBL</messagesenderidentifier>
		<messagereceiveridentifier>EVVETPROD</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20111226151105</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<reportid>EU-AUTO-VETADRAr_E2001</reportid>
		<reporttype>1</reporttype>
		<informationtype>1</informationtype>
		<casetype>2</casetype>
		<casenumber>EU-AUTO-VETADRAc_E2001</casenumber>
		<originalreceivedateformat>102</originalreceivedateformat>
		<originalreceivedate>20111002</originalreceivedate>
		<mostrecentinfodateformat>102</mostrecentinfodateformat>
		<mostrecentinfodate>20111009</mostrecentinfodate>
		<primarysourcecountry>BG</primarysourcecountry>
		<occurcountry>BG</occurcountry>
		<htermversion>11.0</htermversion>
		<veddraversion>11.0</veddraversion>
		<nullificationreport>2</nullificationreport>
		<nullificationreason/>
		<suspectduplicate>1</suspectduplicate>
		<treatedspeciesandbreeds>
			<speciescode>CAMCA</speciescode>
		</treatedspeciesandbreeds>
		<othertreatedanimaldata>
			<exposednumber>23</exposednumber>
			<sex>2</sex>
			<animalrole>1</animalrole>
			<comments>Sample Comment</comments>
		</othertreatedanimaldata>
		<humanaffected>
			<patientid>23</patientid>
			<hexposednumber>100</hexposednumber>
			<haffectednumber>80</haffectednumber>
			<reactiononsettime>2</reactiononsettime>
			<onsetage>45</onsetage>
			<onsetunit>804</onsetunit>
			<agegroup>5</agegroup>
			<humansex>1</humansex>
			<categorization>3</categorization>
			<humanadversereaction>
				<overallstartdateformat>102</overallstartdateformat>
				<overallstartdate>20111001</overallstartdate>
				<duration>28</duration>
				<durationunit>800</durationunit>
				<overallenddateformat>102</overallenddateformat>
				<overallenddate>20111201</overallenddate>
				<outcome>5</outcome>
				<humancasenarrative>
					<narrativeincludeclinical>SampleNarrativeIncludeClinical INFORMATION OF EXPOSURE / CASE HISTORY</narrativeincludeclinical>
				</humancasenarrative>
				<humansign>
					<reactiontermcode>2010</reactiontermcode>
					<reactionhterm/>
				</humansign>
			</humanadversereaction>
			<humansuspectdrug>
				<exposurestartdateformat>102</exposurestartdateformat>
				<exposurestartdate>20111001</exposurestartdate>
				<exposureduration>28</exposureduration>
				<exposuredurationunit>805</exposuredurationunit>
				<exposureenddateformat>102</exposureenddateformat>
				<exposureenddate>20111202</exposureenddate>
				<characterization>2</characterization>
				<brandname>ACQUA PER PREPARAZIONI INIETTABILI - SOLVENTE</brandname>
				<dosageform>9</dosageform>
				<authorizationnumber>6.786/99</authorizationnumber>
				<authorizationcompany>Acqua Laboratories</authorizationcompany>
				<authorizationcountry>BG</authorizationcountry>
				<obtaincountry>BG</obtaincountry>
				<lotnumber>72201E21</lotnumber>
				<expiringdateformat>610</expiringdateformat>
				<expirydate>201210</expirydate>
				<administrationroute>4</administrationroute>
				<exposurereason>7</exposurereason>
				<doseperadministration>1</doseperadministration>
				<numberdoseperinterval>1</numberdoseperinterval>
				<doseinterval>1</doseinterval>
				<doseintervalunit>805</doseintervalunit>
				<doseunit>1</doseunit>
				<exposuredetails>1 Dose Once</exposuredetails>
				<actiontakenafterreaction>2</actiontakenafterreaction>
				<atcvetcode>QG03XB90</atcvetcode>
				<administrationvmp>6</administrationvmp>
				<humanassessment>
					<assessmentsource>2</assessmentsource>
					<assessmentclassification>2</assessmentclassification>
					<assessmentcomment>Sample Assessment Comment</assessmentcomment>
				</humanassessment>
				<humansuspectsubstance>
					<role>1</role>
					<characterization>2</characterization>
					<name>DEXTROPROPOXYPHENE NAPSILATE</name>
					<strength>1</strength>
					<strengthunit>119</strengthunit>
				</humansuspectsubstance>
			</humansuspectdrug>
			<humantreatingdrug>
				<startdateformat>102</startdateformat>
				<startdate>20111001</startdate>
				<duration>1</duration>
				<durationunit>805</durationunit>
				<enddateformat>102</enddateformat>
				<enddate>20111208</enddate>
				<brandname>AFOXOLANER 11.3 mg - CHEWABLE TABLET</brandname>
				<authorizationnumber>DIN 01909991</authorizationnumber>
				<authorizationcompany>Comp no1</authorizationcompany>
				<authorizationcountry>BG</authorizationcountry>
				<dosageform>4</dosageform>
				<administrationroute>78</administrationroute>
				<dosagetext>dosag text</dosagetext>
				<humantreatingsubstance>
					<name>DIBENZEPIN HYDROCHLORIDE</name>
					<strength>1</strength>
					<strengthunit>46</strengthunit>
				</humantreatingsubstance>
			</humantreatingdrug>
			<humanmedicalhistory>
				<episodecode>2073</episodecode>
				<episodename>Abdominal cavity haemorrhage</episodename>
				<primarysourceepisodename>SamplePrimarySourceEpisodeName</primarysourceepisodename>
				<comments>Comment</comments>
			</humanmedicalhistory>
			<humanlaboratorytest>
				<testnamecode>8</testnamecode>
				<testname>140</testname>
				<description>Sample Test description</description>
				<testresultrange>7</testresultrange>
			</humanlaboratorytest>
			<humandeath>
				<authopsydone>1</authopsydone>
				<humandeathdateformat>102</humandeathdateformat>
				<humandeathdate>20111220</humandeathdate>
				<primarysourcedeathcause>SampleDeathCause</primarysourcedeathcause>
				<deathcausecode>2164</deathcausecode>
				<deathcause/>
				<furtherinfo>SampleFurtherInfo</furtherinfo>
			</humandeath>
		</humanaffected>
		<rechallengeinformation>
			<previousexposure>2</previousexposure>
			<previousar>2</previousar>
			<abateafterstopping>2</abateafterstopping>
			<reappearafterreintroduction>2</reappearafterreintroduction>
		</rechallengeinformation>
		<sender>
			<firstname>Jos</firstname>
			<middlename>MiddleNm</middlename>
			<lastname>Olaerts</lastname>
			<streetaddress>7 Westferry Circus</streetaddress>
			<city>London</city>
			<state>State</state>
			<postcode>E14 4HB</postcode>
			<country>BG</country>
			<telephone>44207418-8624</telephone>
			<fax>44207418-8670</fax>
			<email>jos.olaerts@ema.europa.eu</email>
			<organization>EVVETPRODBL</organization>
			<department>QCT</department>
			<categorization>2</categorization>
		</sender>
		<literaturereference>
			<reference>SampleReftext</reference>
		</literaturereference>
		<clinicaltrial>
			<studyname>SampleStudyName</studyname>
			<sponsorstudynumber>SampleStudyNumber</sponsorstudynumber>
			<observestudytype>2</observestudytype>
		</clinicaltrial>
		<linkedreport>
			<casenumber>T000_P_VETADR_H</casenumber>
			<linktype>1</linktype>
		</linkedreport>
		<primarysource>
			<firstname>pFirstNm</firstname>
			<middlename>pMiddleNm</middlename>
			<lastname>pLastNm</lastname>
			<streetaddress>Street</streetaddress>
			<city>pCity</city>
			<state>pState</state>
			<postcode>pE144HB</postcode>
			<country>BG</country>
			<telephone>54207418-8624</telephone>
			<fax>54207418-8670</fax>
			<email>primary@ec.om</email>
			<organization>pEMA</organization>
			<department>pQCT</department>
			<categorization>4</categorization>
		</primarysource>
		<otherpeople>
			<firstname>oFirstNm</firstname>
			<middlename>oMiddleNm</middlename>
			<lastname>oLastNm</lastname>
			<streetaddress>Street</streetaddress>
			<city>oCity</city>
			<state>oState</state>
			<postcode>oE144HB</postcode>
			<countrycode>BG</countrycode>
			<telephone>64207418-8624</telephone>
			<fax>64207418-8670</fax>
			<email>other@de.com</email>
			<organization>oEMA</organization>
			<department>oQCT</department>
			<categorization>3</categorization>
		</otherpeople>
		<duplicatereport>
			<duplicatesource>SampleDuplicateSouruce</duplicatesource>
			<duplicatenumber>1234567890</duplicatenumber>
		</duplicatereport>
	</safetyreport>
</vetsafetymessage>
